(Q44567375)

English

A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus

scientific article published in July 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giuseppe Derosa

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Arrigo F. Cicero

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Leonardina Ciccarelli

3

object named as

Leonardina Ciccarelli

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

object named as

Roberto Fogari

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2006-2021

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Diabetes and cardiovascular risk factors: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of hypertension in adult patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetic and hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypotensive therapy reduces microvascular albumin leakage in insulin-dependent diabetic patients with nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension in diabetic patients. An overview of interventional studies to preserve renal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hypertensive patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

AT(1)-receptor blockers: differences that matter

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of angiotensin converting enzyme inhibitors on the arterial wall

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Vibratory perception in diabetics during arrested blood flow to the limb

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of total serum insulin (IRI) in insulin-treated diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass: A randomized, double-blind, controlled study of 21 obese hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive Effect and Tolerability of Perindopril in Indian Hypertensive and Type 2 Diabetic Patients: 1-Year Randomised, Double-Blind, Parallel Study vs Atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-Converting Enzyme Inhibitors and Insulin Sensitivity: Metabolic Effects in Hypertension, Diabetes, and Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980201-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80201-1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44567375&oldid=2028201148"